ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-PI Brilique 90mg Tablets

G Pharma Ltd have informed the MHRA that there is an error in the spelling of the active ingredient included on the imported carton. The spelling should be ‘Ticagrelor’ but has been printed as ‘Tricagelor’ under the brand name and in the content statement.

 

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-notification-brilique-90mg-tablets-el-25-a-slash-18?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=338050a1-7c68-4c7d-9ebb-14fee1ccad21&utm_content=immediately

 

MHRA drug alert date: 24/04/25

 

Pip code

Product description

Supplier

Batch Numbers

Alliance do not stock

PI BRILIQUE TAB 90MG

G Pharma Ltd

200507(OMB VHVK)

200942 (OMB VHXF)

201136 (OMB VHXF)

 

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For all medical information enquiries please email ddavies@gpharma.co.uk, or telephone 0161 888 7317. For stock control enquiries please email ddavies@gpharma.co.uk or telephone 0161 888 7317.